Page last updated: 2024-08-24

atorvastatin and Arrhythmias, Cardiac

atorvastatin has been researched along with Arrhythmias, Cardiac in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakhtiarian, A; Hojati, V; Mousavi, Z; Najjari, M; Nikoui, V; Vaezi, G1
Hu, SD; Qu, Y; Xia, JG; Xu, D; Xu, J; Yin, CL1
Bian, B; Nie, J; Teng, T; Wang, Q; Yu, X1
Chen, WR; Chen, YD; Liu, HB; Sha, Y; Shi, XM; Shi, Y; Wang, H; Yin, DW1
Angermann, C; Bauersachs, J; Frantz, S; Heinrich, F; Krane, V; Lilienthal, J; Meesmann, M; Olschewski, M; Störk, S; Wanner, C1
Bacova, B; Barancik, M; Knezl, V; Kolenova, L; Mitasikova, M; Navarova, J; Radosinska, J; Tribulova, N; Weismann, P1
Böhm, M; Fries, R1
Kumagai, K; Nakashima, H; Saku, K1
Esberg, D; Kowey, P1
Ferjan, M; Golicnik, A; Okrajsek, R; Radovancevic, B; Starc, V; Vrtovec, B1
Chen, L; Huang, J; Qian, H; Shen, D; Tang, Q; Wang, H; Wang, T; Wu, H; Xiong, R1
Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC1

Reviews

1 review(s) available for atorvastatin and Arrhythmias, Cardiac

ArticleYear
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
    Medizinische Klinik (Munich, Germany : 1983), 2003, Jun-15, Volume: 98, Issue:6

    Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine

2003

Trials

4 trial(s) available for atorvastatin and Arrhythmias, Cardiac

ArticleYear
[Cardioprotective effect and mechanism of intensive lipid modulation on patients with coronary artery disease undergoing noncardiac surgery].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2014, Aug-18, Volume: 46, Issue:4

    Topics: Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Brugada Syndrome; Cardiac Conduction System Disease; Coronary Artery Disease; Elective Surgical Procedures; Heart Conduction System; Heptanoic Acids; Humans; Lipids; Myocardial Infarction; Perioperative Period; Pyrroles

2014
Effects of Statin on Arrhythmia and Heart Rate Variability in Healthy Persons With 48-Hour Sleep Deprivation.
    Journal of the American Heart Association, 2016, 10-31, Volume: 5, Issue:11

    Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atorvastatin; C-Reactive Protein; Double-Blind Method; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Malondialdehyde; Sleep Deprivation; Superoxide Dismutase; Young Adult

2016
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:2

    Topics: Aged; Arrhythmias, Cardiac; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Practice Guidelines as Topic; Predictive Value of Tests; Proportional Hazards Models; Pyrroles; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2009
Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Journal of cardiac failure, 2005, Volume: 11, Issue:9

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atorvastatin; Electrocardiography; Female; Heart Failure; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prospective Studies; Pyrroles; Statistics, Nonparametric; Survival Analysis; Treatment Outcome

2005

Other Studies

7 other study(ies) available for atorvastatin and Arrhythmias, Cardiac

ArticleYear
Involvement of IL-1β and IL-6 in antiarrhythmic properties of atorvastatin in ouabain-induced arrhythmia in rats.
    Immunopharmacology and immunotoxicology, 2018, Volume: 40, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Interleukin-1beta; Interleukin-6; Male; Ouabain; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2018
Atorvastatin protects myocardium against ischemia-reperfusion arrhythmia by increasing Connexin 43 expression: A rat model.
    European journal of pharmacology, 2015, Dec-05, Volume: 768

    Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Connexin 43; Creatine Kinase, MB Form; Cytoprotection; Disease Models, Animal; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardium; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Up-Regulation

2015
Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2010, Volume: 61, Issue:6

    Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; Blood Pressure; Connexin 43; Fatty Acids, Omega-3; Heart Rate; Heart Ventricles; Heptanoic Acids; Hypertriglyceridemia; Myocardium; Myocytes, Cardiac; Phosphorylation; Pyrroles; Rats; Rats, Wistar; Triglycerides; Up-Regulation; Ventricular Fibrillation

2010
The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.
    Cardiovascular research, 2004, Apr-01, Volume: 62, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Atorvastatin; C-Reactive Protein; Dogs; Female; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Models, Animal; Pericarditis; Pyrroles; Random Allocation

2004
Does "anti-lipid" also mean "anti-arrhythmic"?
    Journal of cardiac failure, 2005, Volume: 11, Issue:9

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atorvastatin; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles

2005
Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
    Life sciences, 2007, Jan-23, Volume: 80, Issue:7

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atorvastatin; Autoimmune Diseases; Disease Models, Animal; Heart; Heart Ventricles; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Pyrroles; Tumor Necrosis Factor-alpha; Ventricular Function

2007
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
    The American journal of cardiology, 2000, Nov-15, Volume: 86, Issue:10

    Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome

2000